Results: Activation areas in SD, compared with controls, were in right inferior frontal gyrus, right supramarginal gyrus, right middle temporal gyrus, and right superior temporal gyrus. On the contrary, decreased brain activity in SD group was observed in bilateral primary sensory area, right inferior parietal cortex, bilateral precentral gyrus, bilateral rolandic operculum, bilateral SMA, left anterior cingulate cortex, bilateral middle cingulate gyrus, right temporal pole, right superior pole, bilateral cerebellum, left inferior frontal gyrus, right insula lobe, bilateral thalamus, and right basal ganglia.
Objective: 1) Understand the presentation, etiology, and management of bilateral vocal fold immobility. 2) Understand the utility, technique, and advantage of endoscopic coblation vocal cordotomy for patients with bilateral vocal fold immobility. 3) Compare the use of the laryngeal coblator with the laser.
Method: Case series using endoscopic coblation to perform vocal cordotomy in patients with bilateral vocal fold immobility is presented. Seven patients underwent suspension microlaryngoscopy with either initial or revision vocal cordotomy with or without partial arytenoidectomy. Routine follow-up was performed and wound healing was documented via distal chip videolaryngoscopy.
Results: Seven patients underwent suspension microlaryngoscopy with vocal cordotomy as part of airway management for bilateral vocal fold immobility. The laryngeal coblator was used to perform a transverse cordotomy. The procedure was completed in approximately 5 minutes. No laser protection is required reducing operative set-up and procedure time versus the laser. Two patients had a prior tracheotomy. No patients required a tracheotomy with this procedure. Patients were seen between 1 day and 1 month postoperatively. Patients had minimal granulation tissue at the cordotomy site and appeared to have quicker healing. The glottic airway and stridor were improved in all patients.
Conclusion: Initial outcomes of endoscopic coblation vocal cordotomy reveal this technique to be safe and efficient. Coblation increased the glottic airway with minimal granulation tissue and rapid healing. This represents the first described use of coblation for bilateral vocal fold immobility. Long-term data will be forthcoming.
Laryngology/Broncho-Esophagology Cyclooxygenase inhibition of LtC Stenosis in the Mouse Model
Jennifer Y. Lee, MD (presenter); Sunil Singhal, MD; Kevin Leahy, MD, PhD; Noam A. Cohen, MD, PhD; Genevieve Philiponis; Ankona Ghosh, MD; Natasha Mirza, MD Objective: The study explores possible therapies to decrease or prevent subglottic stenosis. We aim to study the effects of cyclooxygenase (COX) inhibition on laryngotracheal granulation and stenosis in a previously described murine model.
Method:
Laryngotracheal complexes (LTC) were transplanted into a previously established recipient mouse model. Treatment group (n = 4) received COX inhibitor chow for 3 weeks. Control group (n = 4) did not. After 3 weeks, LTCs were harvested and examined microscopically for comparison. Relative levels of IL-1, COX2, and TGF beta were compared using RT-PCR.
Results: Comparison of hematoxylin and eosin staining of granulation tissue showed no difference in lamina propria thickness between LTCs that received COX inhibitor or LTCs that did not. Also, no difference in lamina propria thickness was noted between different types of injury such as acid or wire brush. Furthermore, no further differences were noted in the RT-PCR results in the samples.
Conclusion:
Inhibition of cyclooxygenase (COX) does not lead to significant differences in granulation formation or in cytokine levels in the murine model of subglottic stenosis.
Laryngology/Broncho-Esophagology Diffusion of aniline Blue injected into thyroarytenoid Muscle
Adriana Hachiya, MD (presenter); Valéria M. O. Alonso, MD; Imamura Rui, MD; Natasha M. Braga, MD; Domingos H. Tsuji, MD; Luis U. Sennes, MD Objective: Intralaryngeal injection of botulinum toxin into the thyroarytenoid (TA) muscle is one of the methods for the treatment of laryngeal focal dystonia. The side effects and the modification of the laryngeal configuration are probably due to the diffusion of the botulin toxin to nearby structures. Aim: Analyze the diffusion of aniline blue (liquid substance) injected into the TA to the adjacent intrinsic laryngeal muscles.
Method: Study Design: Experimental. Eighteen excised cadaveric larynges were analyzed after injection of aniline blue (0.2 mL) into the TA, using the intralaryngeal technique. After fixation by formaldehyde and decalcification using nitric acid, the larynges were sectioned in the coronal plane in 4 slices and the intrinsic muscles analyzed.
Results:
The aniline blue spread to the lateral cricoarytenoid muscle, the cricothyroid muscle and the posterior cricoarytenoid muscle 94.3%, 42.9%, and 8.6%, respectively. Gender, height, and width of the TA had no effect on the likelihood of diffusion to any of the muscles.
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Conclusion: The present study showed that, based on the methodology proposed, the diffusion of a solution injected into the TA occurs in almost all cases toward the CAL muscle. The CT muscle was affected in half of the cases. Although rarely, it can also achieve the PCA muscle.
Laryngology/Broncho-Esophagology
Disease-Specific Self-efficacy in Spasmodic Dysphonia Amanda Hu (presenter); Derek Isetti; Al Hillel, MD; Pat Waugh, MS, CCC-SLP; Tanya K. Meyer, MD Objective: Self-efficacy (SE) is an optimistic self-belief that one can cope with adversity. For chronic conditions, a standardized measure of SE is a strong predictor of health behaviors. Our objectives were to study SE in spasmodic dysphonia (SD) and to develop a disease-specific SE-SD scale.
Method: Disease-specific SE-SD items were developed through expert opinion. These items, general SE scale, Voice Handicap Index (VHI), Consensus Auditory Perceptual Evaluation of Voice (CAPE-V), and Hospital Anxiety and Depression Scale (HADS) were administered to SD patients who presented to University of Washington for botulinum toxin injections over a 6-month period.
Results: Eighty SD patients completed the study with a mean age 58.7 years. The general self-efficacy score (Cronbach's α = .871) was 34.7 ± 3.7 out of 40 and was negatively correlated with VHI (r = -0.22, P = .08), CAPEV (r = -0.14, P = .36), and HADS-A (r = -0.50, P < .001) and HADS-D (r = -0.53, P < .001). Factor analysis was performed and selected 7 items from the general self-efficacy scale and 6 diseasespecific SE-SD items to generate a 13-item disease specific SE-SD scale (Cronbach's α = .913). Disease-specific SE-SD score was 43.9 ± 5.6 out of 52 and is negatively correlated with VHI (r = -0.35, P = .001), CAPE-V (r = -0.29, P = .026), HADS-A (r = -0.49, P < .001), and HADS-D (r = -0.58, P < .001).
Conclusion: SD patients who are established with botulinum toxin injections have a high degree of general SE and diseasespecific SE. Patients with higher SE demonstrate higher subjective and objective vocal quality and lower levels of anxiety and depression. A 13-item disease specific SE-SD scale has been developed.
Laryngology/Broncho-Esophagology Experimental Laryngeal Granuloma in Rats with GERD
Rintaro Shimazu, MD (presenter); Yuichiro Kuratomi, MD, PhD; Akira Inokuchi Objective: Acid reflux and mucosal injury of the larynx may be involved in the development of laryngeal granuloma. This study developed an experimental laryngeal granuloma by mechanical injury to the vocal cord mucosa in rats with chronic acid refluesophagitis to clarify the pathological mechanism of laryngeal granuloma.
Method: An experimental rat model of chronic acid reflux esophagitis was surgically created. A plastic bar was inserted into the trachea of the model rat to mechanically injure the vocal cord mucosa. The pharynx, larynx, and esophagus of these rats were observed histologically every 2 weeks after the operation.
Results:
A granuloma was observed in the vocal cord mucosa of the rat after 2 weeks of the surgery, and this presented the same pathological structure as human laryngeal granuloma. In contrast, only mucosal abrasions and blister formations of the vocal cord mucosa were observed in the control rats without surgery.
Conclusion:
The current results showed both mechanical injury and acid refluwas involved in the development of a laryngeal granuloma.
Laryngology/Broncho-Esophagology incidence of all-Cause Chronic Laryngitis
Daniel J. Stein (presenter); Jacob P. Noordzij, MD Objective: 1) Appreciate the most common causes of chronic laryngitis. 2) Understand the incidence of chronic laryngitis in a primary care population. 3) Describe the demographic profile of patients who present to care for treatment of chronic laryngitis.
Method:
A review identified patients diagnosed with chronic laryngitis among an urban academic medical center primary care population from 2009 to 2010. One hundred subjects with chronic laryngitis were selected, and symptoms, firstvisit treatment, smoking, and demographics were recorded. Incidence was calculated by comparison to an existing database of all cases of idiopathic chronic laryngitis.
Results: Yearly incidence of chronic laryngitis was 19.5 per 1000 people. The 100 subjects consisted of 62 women and 38 men. Race was recorded as black (46), Hispanic (25), white (17), other (12). Age ranged from 20 to 75 years, with a mean of 52.6 years (standard deviation, 12.6 years). Therapies included a proton-pump inhibitor (77%), voice therapy (21%), nasal steroid (15%), anti-histamine (6%), amitriptyline (4%), and no treatment (10%). The most common symptoms reported were cough hoarseness (59%), cough (37%), pain/ soreness (37%), globus (36%), excessive throat clearing (31%), subjective dysphagia (26%), and throat irritation (19%). 92% were seen by an otolaryngologist.
Conclusion:
We found a yearly chronic laryngitis incidence of 19.5 per 1000 people. In an academic setting, most of these will present to otolaryngologists. The majority was treated using proton pump inhibitors. Hoarseness, cough, and pain
